XML 28 R18.htm IDEA: XBRL DOCUMENT v3.19.1
Leases
3 Months Ended
Mar. 31, 2019
Leases  
Leases

11.  Leases

 

The Company has operating leases for office space and laboratory facilities, and finance leases for fleet vehicles leased for its sales force and laboratory equipment.  The components of lease expense were as follows:

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

 

     

2019

     

Operating lease expense

    

$

143

    

 

 

 

 

 

Finance Leases:

 

 

 

 

Amortization of right-to-use assets

 

$

170

 

Interest expense

 

 

38

 

Total finance lease expenses

 

$

208

 

 

During the three months ended March  31, 2018 the Company recorded $276 of rent expense which was recognized on a straight-line basis over the term of the lease. 

Operating Leases

 

Agreements for Office Space

 

In November 2017, the Company entered into a sublease agreement with Auxilium Pharmaceuticals, LLC (the “Sublandlord”) pursuant to which it subleases 33,019 square feet of office space for its headquarters in Wayne, Pennsylvania.  Subject to the consent of Chesterbrook Partners, LP (“Landlord”) as set forth in the lease by and between them and Sublandlord, the sublease has a term that runs through October 2023.  If for any reason the lease between the Landlord and Sublandlord is terminated or expires prior to October 2023, the Company’s sublease will automatically terminate. 

 

In February 2019, the Company entered into a sublease agreement with a third party for 21,056 square feet of office and laboratory space in St. Louis,  Missouri with total future total rent payments of $3,538.  The Company has also agreed to pay $1,472 of the total renovation and improvement costs incurred by the landlord, which is collateralized by a standby letter of credit held by the Company.  The lease term commences on the first day of the month following the landlord’s completion of renovations to the building and continues for a period of 10 years.    The Company expects the lease term to commence by the end of the first half of 2019. 

 

Supplemental balance sheet information related to operating leases is as follows: 

 

 

 

 

 

 

 

 

 

March 31, 

 

Operating Leases:

 

2019

 

Gross cost

 

$

2,156

 

Accumulated amortization

 

 

(88)

 

Operating lease right-of-use assets

 

$

2,068

 

 

 

 

 

 

Other current liabilities

 

$

373

 

Other liabilities

 

 

1,851

 

Total operating lease liabilities

 

$

2,224

 

 

 

Finance Leases

 

Laboratory Equipment

 

The Company leases laboratory equipment which is used in its laboratory space in St. Louis, Missouri under two lease financing arrangements which the Company entered into in August 2017 and October 2017, respectively.  The leases have terms which end in October 2020 and December 2020, respectively. 

 

Fleet Vehicles

 

The Company leases automobiles for its sales force and other field-based employees under the terms of a master lease agreement with a third party.  The lease term for each automobile begins on the date the Company takes delivery and continues for a period of four years. 

 

 

Supplemental balance sheet information related to finance leases is as follows: 

 

 

 

 

 

 

 

 

 

March 31, 

 

Finance Leases:

 

2019

 

Property and equipment, gross

 

$

2,557

 

Accumulated depreciation

 

 

(620)

 

Property and equipment, net

 

$

1,937

 

 

 

 

 

 

Other current liabilities

 

$

495

 

Other liabilities

 

 

1,301

 

Total finance lease liabilities

 

$

1,796

 

 

Supplemental information related to operating and finance leases is as follows:

 

 

 

 

 

 

 

 

Three Months Ended

 

 

 

March 31, 

 

Supplemental Cash Flow Lease Information:

 

2019

 

Operating cash flows from operating leases

 

$

141

 

Operating cash flows from finance leases

 

 

31

 

Financing cash flows from finance leases

 

 

120

 

 

 

 

 

 

Lease liabilities arising from new operating leases

 

$

 —

 

Lease liabilities arising from new finance leases

 

 

 —

 

 

 

 

 

 

 

 

 

 

 

Weighted-Average Remaining Lease Term (in years):

 

 

 

 

Operating leases

 

 

4.58

 

Finance leases

 

 

2.97

 

 

 

 

 

 

Weighted-Average Discount Rate:

 

 

 

 

Operating leases

 

 

6.97

%

Finance leases

 

 

10.10

%

 

 

Future maturities of lease liabilities under operating and finance leases as of March 31, 2019 are as follows:

 

 

 

 

 

 

 

 

 

 

 

Operating

 

 

Finance

Year Ending December 31, 

    

 

Leases

 

 

Leases

2019

 

$

431

 

$

443

2020

 

 

589

 

 

567

2021

 

 

605

 

 

448

2022

 

 

622

 

 

169

2023

 

 

532

 

 

 —

Total undiscounted lease payments

 

 

2,779

 

 

1,627

Less: unrecognized interest

 

 

(555)

 

 

(217)

Plus: residual value guarantees

 

 

 —

 

 

386

Total lease liability

 

$

2,224

 

$

1,796

 

The undiscounted lease payments presented in the table above are consistent with the future minimum lease payments disclosed in the Company’s Annual Report on Form 10-K filed with the SEC on March 18, 2019 under the prior lease guidance.